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ABSTRACT 
 
Nestin, a class VI intermediate filament (nanofilament) protein, is 
commonly used as a marker for neural stem/progenitor cells (NSPCs), 
but its role in neurogenesis remains elusive. Nestin is also expressed in 
immature and reactive astrocytes. The up-regulation of intermediate 
filament proteins glial fibrillary acidic protein (GFAP), vimentin and 
nestin is a characteristic feature of reactive astrocytes, accompanied by 
alterations in the expression of many other genes. We found that 
transgenic mice deficient for nestin have increased number of newly 
born hippocampal neurons 6 weeks after BrdU in vivo labeling, 
suggesting increased generation and/or survival of newly born neurons. 
We also showed that in vitro nestin deficient astrocytes provide a more 
pro-neurogenic environment that results in a 2-fold increase in 
neuronal differentiation of NSPCs. 
Astrocytes are highly heterogeneous cells and fulfill a variety of 
important functions in healthy as well as diseased brain. In addition, 
astrocytes can exhibit features characteristic of NSPCs and modulate 
neurogenesis by inhibiting neuronal differentiation of NSPCs through 
Jagged1-mediated Notch signaling. Given the vast array of astrocyte 
functions, classification of astrocyte subpopulations on a molecular 
level is highly desirable. We used single cell quantitative real-time 
PCR to investigate the heterogeneity of astrocytes with respect to their 
Notch signaling competence. Our results show that the Notch signal 
sending but not Notch signal receiving competence of astrocytes 
depends on GFAP and vimentin. Further, we showed that nestin and 
heparin binding EGF-like growth factor (HB-EGF) may serve as 
classifiers of astrocyte subpopulations in vitro.  
Utilizing our newly developed Bioactive3D and standard 2D cell 
culture systems, we showed that HB-EGF alters astrocyte morphology 
towards a more radial glia-like phenotype. HB-EGF affects 
proliferation, differentiation and expression of Notch signal pathway 
related genes and leads to the up-regulation of nestin expression. HB-
EGF in cell culture media results in partial de-differentiation of 
astrocytes and therefore should be used with caution. 
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HB-EGF  Heparin binding epidermal growth factor-like growth  
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1 INTRODUCTION 
1.1 Development of the mammalian central nervous system 
(CNS) 
1.1.1 The major cellular players of the CNS 
The mammalian central nervous system (CNS) consists of three 
parts: the brain, the retina and the spinal cord. Functions of the spinal 
cord are e.g. to conduct sensory information from the peripheral 
nervous system to the brain and to control simple muscle reflexes. The 
brain is responsible for the integration and evaluation of the sensory 
information and coordination of conscious or unconscious responses 
and, in addition, for complex functions such as thinking, memory and 
emotions. 
The major cellular players within the mammalian CNS are 
neurons and glial cells. The CNS consists of roughly the same number 
of neurons and glial cells, however the neuron-glia ratio depends on 
the CNS region [1]. In addition, the ratio is increased in organisms of 
higher taxonomy as is the morphological complexity of astrocytes [2]. 
Neurons are defined as electrically excitable cells, which convey 
information through electrical action potentials or through chemical-
induced signal transduction via neurotransmitters. Neurons are a highly 
heterogeneous cell class based on their functions and morphology, 
with various subpopulations, such as sensory neurons, interneurons or 
motoneurons. Glial cells are defined as electrically non-excitable cells 
and comprise macroglial cells, such as astrocytes, oligodendrocytes, 
NG-2 glia, and microglia in the CNS. Oligodendrocytes are equivalent 
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to the Schwann cells of the peripheral nervous system and have 
myelinating function isolating neuronal axons. NG-2 glia are 
oligodendrocyte precursor cells and the most recent identified 
subpopulation of glia. Microglia are the immune cells within the CNS. 
Astrocytes are highly multifunctional cells and play important roles in 
extracellular ion homeostasis, recycling of neurotransmitters, 
neurogenesis and also in CNS regeneration. 
 
1.1.2 Neural stem/progenitor cells in CNS development 
The development of the CNS starts during early embryogenesis 
within the one-layered neuroepithelium of the neural plate, which later 
forms the neural tube. Neural stem cells (NSCs) of the neural tube 
(neuroephitelial cells), characterized by unlimited self-renewing 
capability and multi-potency, generate the two major cell classes of the 
CNS, neurons and macroglia (astrocytes, oligodendrocytes and NG-2 
glia), while microglia are generated by mesodermal stem cells. NSCs 
divide symmetrically, generating two daughter NSCs until the onset of 
neurogenesis (embryonic day 9-10 in mice). After the onset of 
neurogenesis, NSCs start to divide asymmetrically to generate one 
NSC and a more differentiated neural progenitor cell (NPC), which is 
restricted in its possible lineage development to neurons. With the 
onset of neurogenesis, the neuroepithelium becomes multilayered and 
most neuroephitelial cells change their molecular properties (e.g. 
down-regulation of tight junctions) and start to show some astrocyte 
features, such as the presence of glutamate transporters, and are named 
radial glia cells, that give either rise directly to neurons or differentiate 
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into neural intermediate progenitor cells (capable to generate neurons 
or macroglial cells) through asymmetric division. In most regions of 
the mouse CNS, the molecular shift from neuroepithelial cells to radial 
glia cells occurs between embryonic day 10 – 12. Most radial glia cells 
are lineage restricted to neurons, astrocytes or oligodendrocytes and 
they serve as a migration scaffold for neurons. The onset of generation 
of the macroglial cells (gliogenesis), astrocytes (astrogenesis) and 
oligodendrocytes (oligodenrocytogenesis), occurs after the onset of 
neurogenesis in CNS development, with the peak of astrogenesis at 
perinatal time points and the peak of oligodendrocytogenesis at 
postnatal time points (Fig. 1; for review see [3]).  
Fig.1 Development of the major cell types within the CNS. During embryogenesis 
neurogenesis starts first, followed by astrogenesis that lasts into perinatal and postnatal time 
points. Oligodendrocytogenesis starts perinatal and lasts into adulthood.  Modified after 
Verkhratsky & Butt, Glial Physiology and Pathophysiology, 2013. 
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1.2 Adult neurogenesis 
 
1.2.1 Neurogenesis in the adult CNS occurs in two distinct regions 
The traditional view of neurogenesis in the CNS was that 
generation of neurons from neuroepithelial cells and/or radial glia cells 
occurs only during embryogenesis and perinatal stages. Studies by J. 
Altman 50 years ago provided the first evidence of postnatal 
neurogenesis in rat hippocampi [4]. Functional integration of newly 
born neurons in adults was first shown in songbirds in 1984 [5] and in 
1992 NSCs were first isolated from adult mammalian brain [6, 7].  
The capacity of the healthy adult mammalian CNS to generate 
and functionally integrate new neurons into existing neuronal networks 
is extremely limited under physiological conditions in comparison to 
the developing CNS. In addition, within the healthy CNS adult 
neurogenesis occurs in two distinct neurogenic niches only, namely the 
subventricular zone (SVZ) of the lateral ventricles and the subgranular 
zone (SGZ) of the hippocampal dentate gyrus (Fig. 2), while 
gliogenesis in the adult brain is not restricted to specific niches. Newly 
born neurons in the SVZ migrate along the rostral migratory stream 
into the olfactory bulb and replace interneurons throughout the 
lifespan. Newly born neurons in the SGZ of the dentate gyrus are 
capable to integrate into existing hippocampal neuronal networks but 
remain within the hippocampus (for review see [8]). The survival and 
functional integration of newly born neurons is affected by 
intracellular factors, such as cell-cycle regulators and transcription 
factors, extracellular factors, such as cell-cell signaling mechanisms, 
released growth factors or hormones (for review see [9]) but also by 
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external stimuli of the environment, such as learning and memory, 
enriched environment, physical activity, stress or diet [10-15]. 
Fig. 2 The neurogenic niches within the adult rodent brain. New-born neurons are either 
generated in the subventricular zone of the lateral ventricles (LV) and migrate along the 
rostral mígratory stream (RMS) to the olfactory bulb (OB), where they replace interneurons, 
or in the subgranular zone of the dentate gyrus within the hippocampus, where they are 
integrated into functional neuronal networks. CB, cerebellum. 
 
1.2.2 Neural stem/progenitor cells in the adult brain  
Adult hippocampal neurogenesis has been implicated in 
mechanisms for learning and memory and disturbed adult neurogenesis 
within the SGZ of the dentate gyrus has been associated with 
depression, neuroinflammation and epilepsy. Adult neurogenesis 
within the SVZ of the lateral ventricles has been implicated in 
olfaction. Identification of the neural stem/progenitor cells (NSPCs), 
that give rise to new neurons in the adult CNS, was one of the main 
research subjects in the past years, however the matter of the origin of 
adult-born neurons is still under debate.  
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Recently two non-mutually exclusive models of the origin of 
adult-born neurons were proposed, suggesting that newly born neurons 
in the hippocampus arise either from radial glia-like cells (also known 
as type I cells or type I progenitors) or from non-radial precursors (also 
known as type II cells) that are defined by their expression of the 
progenitor cell marker Sox2 (Fig. 3A). Both cell types reside within 
the SGZ and are considered to be quiescent, slowly dividing NSCs. 
Radial glia-like cells express the astrocyte marker glial fibrillary acidic 
protein (GFAP) and also the stem/progenitor cell marker nestin. 
However, radial glia-like cells or non-radial precursors do not directly 
generate newly born neurons but divide asymmetrically and produce 
intermediate progenitor cells (also known as type D cells). 
Intermediate progenitor cells generate neuroblasts that are integrated 
into the granular cell layer and mature into granule cells. Radial glia-
like astrocytes within the SGZ also maintain the functional properties 
of normal astrocytes. The different origin of newly born neurons in the 
adult may be an indicator for the existence of several subpopulations of 
adult neural stem cells within the CNS. 
In the SVZ of the lateral ventricles NSCs (also named radial 
glia-like cells, type B cells or SVZ astrocytes) give rise to newly born 
neurons (Fig. 3B). Radial glia-like cells express stem cell specific 
markers, such as nestin and Sox2, but also astrocyte specific markers, 
such as GFAP and the glutamate aspartate transporter (GLAST). 
Radial glia-like cells are suggested to be quiescent, slowly dividing 
NSCs that give rise to type C cells (or transient-amplifying progenitor 
cells) that have a high proliferative capability, function as intermediate 
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progenitor cells in the adult SVZ and generate immature neuroblasts 
(type A cells), which subsequently migrate along the rostral migratory 
stream into to olfactory bulb to replace interneurons (for review see 
[16, 17]). 
 
Fig. 3 Schematic illustration of the neurogenic niche in the SGZ of the dentate gyrus (A) 
and the SVZ of the lateral ventricles (B). A) Radial glia-like cells (Type I cells) and non-
radial precursors (Type II cells), located in the granular cell layer of the dentate gyrus, 
generate intermediate progenitor cells. Proliferation of intermediate progenitor cells leads to 
generation of neuroblasts that develop into new granule cells and are finally integrated as 
mature granule cells in the neuronal hippocampal network. B) Radial glia-like cells (B cells) 
in the SVZ generate transient amplifying cells (C cells), which generate immature neuroblasts 
(A cells) that migrate along the rostral migratory stream into the olfactory bulb to replace 
interneurons. 
 
 
1.2.3 The cellular environment of the adult neurogenic niches 
Transplantation studies of NSPCs or neural grafts into various 
regions of the adult CNS showed, that neuronal differentiation of the 
transplanted NSPCs or grafts only occurs in the two adult neurogenic 
niches [18-21]. These findings point to the cellular environment as a 
key modulator for neurogenesis in adult CNS. 
The major cellular players that influence the micro-
environment of the adult neurogenic niches are astrocytes, endothelial 
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and ependymal cells, microglia, mature neurons and the progeny of 
adult NSCs and/or NPCs. NPCs with dividing capability were shown 
to be located closely to the capillaries of the vasculature, implicating 
that vascular derived signals and molecules regulate proliferation of 
NPCs [22, 23]. Astrocytes that are in cell-cell contact with cells of the 
vascular system and connected through gap junctions, can modify the 
effects of blood-derived molecules and can regulate the disposal of 
endothelial-derived cytokines or growth factors. Moreover, astrocytes 
can control proliferation and differentiation of adult NPCs and affect 
migration, maturation and synapse formation through diffusible or 
membrane-attached factors [24]. Besides astrocytes, microglia are also 
known to actively regulate neurogenesis in the adult CNS through 
phagocytosis of apoptotic newly generated neurons in the adult SGZ 
[25].  
 
1.3 Astrocytes 
1.3.1 The functions of astrocytes in healthy brain  
Astrocytes are the most abundant glial cell type within the CNS 
[26]. They constitute 50% of all glial cells, besides oligodendrocytes, 
NG-2 glia and microglia. Under physiological conditions astrocytes are 
often (and wrongly) referred to as “quiescent” astrocytes, since they 
were believed to provide mainly structural support for the CNS. 
However, over the 30 last years, astrocytes were shown to be highly 
complex and multifunctional cells involved in various cellular 
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processes, mechanisms and cell-cell interactions necessary for a 
normally functioning brain [27, 28]. 
Astrocytes are in direct cell-cell contact with neurons, 
oligodendrocytes, microglia, endothelial cells, pericytes and other 
astrocytes, thereby influencing and modulating the environment in the 
brain. Named “astro-cyte” because of their star-shaped morphology, it 
was later shown that astrocytes exhibit a more “bushy” morphology 
with many fine processes [29-31]. This morphology allows one human 
astrocyte to be in contact with up to two million synaptic terminals [2], 
thereby regulating neuronal activity via for example recycling of 
neurotransmitters, such as glutamate [32]. In addition, astrocytes are 
directly involved in synaptogenesis by affecting synaptic plasticity and 
pruning of new synapses [33-36] and were recently shown to actively 
engulf synapses in the developing as well as adult CNS depending on 
neuronal activity [37]. Homeostatic functions of astrocytes include 
regulation of extracellular H+ (for review see [38, 39]) and K+ 
concentration (for review see [40]) as well as regulation of the H20 
transport (for review see [41]). Astrocytes locally regulate cerebral 
blood flow [42, 43] and their end-feet are in contact with endothelial 
cells, thereby regulating the formation and maintenance of the blood-
brain-barrier [44].  
Astrocytes cannot communicate with each other electrically 
through action potentials like neurons, but they are connected by gap 
junctions into so-called astrocyte syncytia and communicate through 
Ca2+ waves and other molecules [45]. Release of molecules by 
astrocytes (gliotransmission) affects neuronal differentiation, 
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proliferation and morphology (see also 1.2.3 The cellular environment 
of the adult neurogenic niches) and also synaptic strength [46-48]. 
Recently it was shown, that astrocytes affect neurogenesis by actively 
inhibiting neuronal differentiation of NSPCs through Jag-1 mediated 
Notch signaling [49]. 
 
1.3.2 Astrocytes in diseased brain – reactive astrocytes  
Upon CNS injury, neuroinflammation, neurotrauma, such as 
stroke, or neurodegenerative diseases, such as Alzheimer’s disease or 
Parkinson’s disease, astrocytes become reactive [50]. This 
phenomenon is called reactive gliosis and is accompanied by various 
morphological and functional changes of astrocytes [27, 51, 52]. 
Hallmarks of reactive gliosis are hypertrophy of astrocyte processes, 
up-regulation of the cytoskeletal intermediate filament proteins GFAP 
and vimentin and re-expression of nestin. However, the extent of 
astrocyte activation depends on the type and severity of CNS damage 
and changes in morphology, proliferation and alteration of gene 
expression during reactive gliosis is context dependent and differs 
under various pathophysiological conditions [53-55]. Astrocyte 
activation ranges from reversible and time-limited changes in gene 
expression, such as up-regulation of GFAP and re-expression of the 
intermediate filament proteins synemin and nestin [56, 57], to the 
irreversible generation of a glial scar due to proliferation of reactive 
astrocytes near the injury site [52, 58]. A glial scar protects the 
surrounding, healthy tissue from spreading CNS damage [52, 58], but 
also forms a physical barrier for axonal regeneration after the acute 
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stage of injury [59]. However, the (patho-) physiological response of 
the CNS is not restricted to astrocytes becoming reactive, but involves 
a multicellular reaction of all cell types within the CNS [60].  
 
1.3.3 Astrocytes are heterogeneous 
Astrocytes exhibit a high degree of heterogeneity [61, 62] and 
given the highly complex functions of astrocytes in healthy as well as 
diseased CNS, classification of astrocyte subpopulations on a 
molecular level is highly desirable. So far, astrocytes have been 
classified as protoplasmic or fibrous astrocytes, based on their 
morphological structure and their occurrence in gray and white matter, 
respectively [51]. In addition, Bergmann Glia in the cerebellum and 
Müller Glia in the retina have been classified as subpopulations of 
astrocytes based on their morphology, physiological properties, 
expression of specific markers and their response to injury [62, 63]. 
However, it is still a matter of debate, if and how many other astrocyte 
subpopulations exist, which of these exist already in vivo and if some 
of these can be found exclusively in vitro. 
The most common used astrocyte-specific markers are GFAP, 
S100β and glutamine synthetase. The aldehyde dehydrogenase 1 
family, member L1 (Aldh1L1; also known as 10-
formyltetrahydrofolate dehydrogenase) was suggested as an additional 
astrocyte marker, that in healthy brain is present in more astrocytes 
than GFAP [64].  
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1.4 The intermediate filament (nanofilament) system 
1.4.1 Intermediate filaments  
The cytoskeleton of most eukaryotic cells consists of 
microfilaments (actin filaments), microtubules and the intermediate 
filament system. The actin filaments are the thinnest of all cytoskeletal 
components and important for determination of the cell shape as well 
as cell motility, while microtubules are the thickest cytoskeletal 
components and are important for e.g. intracellular transport and cell 
division. In contrast to actin filaments and microtubuli, the expression 
of intermediate filament proteins is highly tissue-specific (Fig. 4) and 
fulfills functions beyond mechanical stability (for review see [65, 66]).  
Intracellular localization and function of mitochondria, the 
Golgi and the nucleus as well as intracellular protein targeting depend 
on intact intermediate filaments. In addition, the intermediate filament 
cytoskeleton was shown to have cytoprotective functions in stress and 
injury situations and act as signaling platform controlling various cell 
responses to stress. Over 70 cytoplasmic and nuclear intermediate 
filament proteins are known and their expression is highly dynamic 
and depends on the developmental stage, the cell- and tissue-type as 
well as on the physiological condition (e.g. healthy versus diseased 
cell/tissue). All intermediate filament protein molecules consist of a 
rod, head and tail domain. The α-helical rod domain is highly 
conserved, while the flanking N-terminal head and C-terminal tail 
domains differ both in amino acid sequence and length. Intermediate 
filament proteins usually form polymers by either homo-
polymerization or hetero-polymerization with each other, a process, 
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which is regulated by phosphorylation/dephosphorylation of threonine 
and/or serine residues of the N-terminal head domain (for review see 
[65]).  
Intermediate filament proteins can be divided into 6 different 
classes depending on their amino acid sequence and protein structure. 
Type I intermediate filament proteins comprise acidic keratins, while 
type II comprise basic keratins. The astrocyte intermediate filament 
proteins GFAP and vimentin belong to class III, while the neuronal 
intermediate filament proteins neurofilament-L, -M, -H and "-
internexin belong to class IV. Intermediate filament proteins 
comprising the nuclear envelope (lamin A, B, C) belong to class V. 
Nestin, a stem cell marker and astrocyte intermediate filament protein 
belongs to type VI intermediate filament proteins (Fig. 4). 
 
Fig. 4 Expression and classification of intermediate filament proteins. The expression of 
intermediate filament proteins is tissue-specific and depends on the developmental stage. All 
intermediate filament proteins can be classified into 6 different subclasses. Modified after 
Toivola et al. 2005.  
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1.4.2 Nestin 
Expression of nestin was first described in neuroephitelial cells 
[67, 68] but ranges from NSPCs, immature astrocytes in the 
developing CNS [68, 69] to developing heart, muscle, kidney and testis 
tissue [70-72].  In the adult brain, nestin expression is maintained in 
NSPCs and radial glia [73] and is induced in reactive astrocytes after 
injury, stroke and in neurodegenerative diseases [56, 74]. Nestin 
expression is often used as a marker specific for NSPCs [68, 75, 76], 
however its functional role in neurogenesis remains elusive. 
Nestin was shown to regulate apoptosis and myoblast 
differentiation via interaction with Cdk5 [77-79]. Further, assembly 
and disassembly of nestin with its polymerization partners (nestin 
cannot self-polymerize [56]) is regulated by the Cdc2 kinase. Together 
with cyclin B, Cdc2 comprises the maturation/M-phase promoting 
factor complex, which regulates the transition within the cell-cycle, 
implicating that nestin is important for dividing and migrating cells 
[80-82]. 
 
1.4.3 Glial fibrillary acidic protein (GFAP) 
Expression of GFAP within the CNS occurs in astrocytes [83] 
and radial glia [84-86] and in the peripheral nervous system in non-
myelin forming Schwann cells and enteric glia cells, but is also 
expressed in ependymal cells, kidney, testis, epidermis, osteocytes, 
chondrocytes, pancreatic and liver tissue [87-93]. After injury GFAP 
expression is up-regulated in reactive astrocytes.  
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GFAP, alone or together with vimentin, is implicated to play a 
role in many fundamental cellular processes, such as astrocyte motility 
and migration [94-96], proliferation [97-101], vesicle trafficking [102-
106], modulation of neuronal activity [107, 108], synaptic plasticity 
[109], glutamate transport and synthesis [110-113], neurite outgrowth 
[114-117] and cytoprotective functions after injury [30, 118-121]. 
So far 10 different splice variants of GFAP are known and 
literature about GFAP gene expression usually relates to the most 
abundant splice form GFAPα (for review see [122]). 
GFAP usually polymerizes with vimentin in astrocytes, but 
cannot polymerize with nestin in the absence of vimentin. GFAP 
replaces nestin as a polymerization partner for vimentin after 
maturation of astrocytes [56]. However, in vimentin deficient 
astrocytes it has been shown that GFAP can polymerize into 
abnormally bundled intermediate filaments [56].  
 
1.4.4 Vimentin 
Expression of vimentin occurs in astrocytes, in cells of 
mesenchymal origin, leukocytes, epithelial cells, fibroblasts and 
developing muscle. Functions of vimentin comprise maintaining cell 
shape, compartmentalization and anchoring of organelles such as the 
nucleus and the endoplasmatic reticulum (for reviews see [65, 66, 123, 
124]). Similar to GFAP, vimentin plays important roles in many 
fundamental cellular processes, such as during wound healing [125, 
126], in mechanotransduction of shear stress [127], cyto-protection 
after CNS injury [30], migration and serves as a signaling platform (for 
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review see [123]). In addition, vimentin is implicated to play a role in 
intracellular vesicle trafficking [102-106] and in astrocyte motility 
[95]. 
In astrocytes, Vimentin cannot polymerize into homodimers in 
the absence of GFAP and forms heterodimers with nestin in immature 
astrocytes and with GFAP in mature astrocytes [56].  
 
1.4.5 The role of intermediate filament proteins in diseases 
The pivotal role of intermediate filament proteins in cellular 
functions and tissue integrity becomes obvious in the disease context. 
So far, 98 clinical disorders are associated with (a) mutation(s) of 
intermediate filament protein genes (Human intermediate filament 
database; www.interfil.org; [128]). To name only a few, mutations in 
keratin 14 or keratin 5 (type I & II intermediate filament proteins) 
cause several forms of epidermis bullosa simplex, an inheritable skin 
blistering disorder. Mutations in GFAP (type III intermediate filament 
protein) can cause Alexander’s disease, a progressive neurological 
disorder, which is fatal within about 10 years after disease onset. 
Characteristic features are accumulation of Rosenthal fibers in 
astrocytes and chronic gliosis. Mutations in peripherin (type III 
intermediate filament protein) and neurofilament-L, -M, -H (type IV 
intermediate filament proteins) are associated with the 
neurodegenerative disease amyotrophic lateral sclerosis (also known as 
Lou Gehrig’s disease), a disorder characterized by loss of motoneurons 
in the spinal cord and the CNS. 
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1.5 Signaling pathways 
1.5.1 Notch signaling pathway 
The Notch signaling pathway is throughout species a highly 
conserved and interconnected mechanism. The Notch signaling 
pathway has a fundamental role during tissue and organ development 
by regulating proliferation, differentiation and apoptosis. It was 
recently shown, that Notch signaling promotes the differentiation of 
NPCs into glial cells [129], decreases neuronal differentiation and 
proliferation [130] and that Notch signaling is necessary to maintain 
the pool of existing NSPCs [131-135]. Dysregulation of Notch 
signaling has been linked to several diseases, developmental defects 
and cancers, such as leukemia (for review see [136-139]).  
The Notch signaling machinery of mammals consists of 4 
known receptors (Notch1-4) and two Jagged (Jag) ligands (Jag1, Jag2), 
3 Delta-like (Dll) ligands (Dll1, Dll3, Dll4) and 2 Delta-like 
homologue (Dlk) ligands (Dlk1, Dlk2). The Notch receptor consists of 
an extracellular domain and an intracellular domain. Shortly, activation 
of the Notch signaling pathway occurs via binding of one of the 
ligands to the Notch extracellular domain of one of the receptors (Fig. 
5). The membrane-tethered receptor is enzymatically cleaved by an 
ADAM/TACE metalloprotease releasing the ligand-bound Notch 
extracellular domain, which is subsequently transendocytosed into the 
Notch ligand expressing cell. This transendocytotic step is essential for 
eliciting Notch signaling. A second enzymatic cleavage by the γ- 
secretase complex releases the membrane-tethered Notch intracellular 
domain from the plasma membrane, which is subsequently 
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translocated to the nucleus and affects gene expression of Notch 
regulated down-stream targets, such as the transcriptional regulators 
Hairy and Enhancer of split (HES; HES1 and HES5). The 
transendocytosed Notch extracellular domain undergoes lysosomal 
degradation, while the ligand is either recycled and represented at the 
membrane or also degraded (for review see [136-139]). 
 
Fig. 5 Simplified illustration of receptor/ligand binding of the Notch signaling cascade. 
Ligands undergo constitutive cycles of recycling and representation at the membrane of the 
signal sending cell. The Notch extracellular domain of the receptor of the signal receiving cell 
binds to the ligand of the signal sending cell (trans interaction) and is subsequently cleaved by 
ADAM/TACE (“the 1. scissor”) which releases the Notch extracellular domain  for 
transendocytosis together with the ligand into the signal sending cell. A second cleavage step 
by the !-sectretase complex (“the 2. scissor”) releases the Notch intracellular domain from the 
membrane of the signal receiving cell. The Notch intracellular domain is translocated to the 
nucleus were it regulates transcription of downstream target genes of the Notch signaling 
pathway. Binding of receptor and ligand, presented on the membrane of the same cell is 
indicated as Cis inhibition. 
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Regulation of the Notch signaling activity occurs on several 
levels, but lacks an enzymatic amplification step. This might be one 
reason for the gene dosage sensitivity, due to haploinsufficiency (a 
diploid organism has one functional copy of a gene, while the other is 
inactive) of Notch signal pathway related genes. Positive and/or 
negative transcriptional feedback loops may amplify only small 
differences in ligand expression that in turn affect the signaling 
between two neighboring cells. In addition, Notch signal activity is 
regulated via cis or trans interactions of the ligands and receptors. 
Trans interactions occur between two neighboring cells, one 
being the signal sending cell (ligand expressing cell) while the other 
receives the signal (receptor expressing cell), cis interactions have 
been proposed to be inhibitory and occur when ligand and receptor are 
presented at the same cell. The ratio of cis and trans interactions can 
modulate signaling activity between neighboring cells. Other crucial 
steps of Notch signal activity regulation are ubiquitination, 
glycosylation and phosphorylation of the receptors and ligands, which 
mark ligands or receptors for degradation or endocytosis with 
subsequent intracellular trafficking. In addition, Notch signal activity 
is always interconnected with multiple signaling pathways, such as the 
EGFR signaling pathway, and the integration of multiple signaling 
mechanisms result in cell fate determinations, such as proliferation, 
differentiation or apoptosis [136-138, 140]. Cross-talk between Notch 
signaling pathway and the EGFR signaling pathway is necessary to 
keep the balance between NSC pool and NPC pool [141], since Notch 
signaling controls self-renewal and identity of NSCs [132, 142, 143], 
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while EGFR signaling promotes proliferation and migration of NPCs 
[144]. 
 
1.5.2 HB-EGF- a ligand for the EGFR signaling pathway 
Heparin binding epidermal growth factor-like growth factor 
(HB-EGF) is one of several known ligands of the EGFR signaling 
pathway. Other ligands comprise the epidermal growth factor (EGF), 
transforming growth factor α (TGF-α), amphiregulin, heregulin, 
epiregulin, betacellulin, epigen and neuregulin 1-4. Further, four 
receptors are known: ErbB1 (also known as EGFR) and ErbB2-4. 
Activation of the EGFR signaling pathway leads to a highly complex 
cascade of down-stream signaling and affects proliferation, migration, 
differentiation or apoptosis of neighboring cells (for review see [145]). 
The receptors of the EGFR signaling pathway belong to the 
tyrosine kinase receptor family and are transmembrane receptors. 
ErbB1 and ErbB4 are able to build functional homo- or heterodimers, 
while ErbB2 has no ligand binding capability and is functional only as 
a heterodimer. Similar, ErbB3 is only functional as a heterodimer, 
since the tyrosine kinase activity of ErbB3 is defect. All known ligands 
of the ErbB receptors contain a EGF domain and are extracellularly 
presented as membrane-bound ligands (for review see [145]). In case 
of HB-EGF, the membrane bound proHB-EGF is cleaved (so called 
ectodomain shedding) by matrix metalloproteinases or a disintegrin 
and metalloproteinases (ADAMs) and the soluble HB-EGF is released 
into the extracellular space. Subsequently, soluble HB-EGF binds to 
the ErbB receptors at neighboring cells and activates the EGFR 
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signaling cascade [146]. However, membrane bound proHB-EGF can 
also bind ErbBs and activate EGFR signaling in a juxtacrine fashion 
[147]. HB-EGF is a known ligand for the receptors ErbB1 and ErbB4. 
Activation of the EGFR signaling cascade via HB-EGF binding to 
ErbB1 results also in activation of the Ras-MAPK pathway affecting 
proliferation. Activation of EGFR signaling via HB-EGF binding to 
ErbB4 is associated with regulation of differentiation (for review see 
[145]). 
Sixty percent of HB-EGF deficient mice die shortly after birth 
[148] and the expression pattern of HB-EGF during CNS development 
suggests a role in maturation of neurons and glial cells [149]. In 
addition, HB-EGF in vivo has a neuroprotective function after 
ischemia [150, 151] and was shown to improve functional recovery 
after stroke [152] and wound healing [153, 154]. HB-EGF in vitro 
increases migration of astrocytes in a scratch-wound model when used 
with the co-factor insulin-like growth factor 1 [155] and functions as a 
potent mitogen for fibroblasts, smooth muscle cells and keratinocytes 
[156]. Recently it was reported that HB-EGF induces de-differentiation 
of Müller glia into multipotent progenitor cells in zebra fish retina 
[157]. In addition, HB-EGF was suggested as a replacement for serum 
in primary astrocyte cultures [158]. Taken together, the functional 
complexity of EGFR signaling, the expression of HB-EGF during 
development as well as its possible role in neuroprotection after injury 
make HB-EGF a highly interesting molecule and a possible target for 
treatment strategies in CNS regeneration. 
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2 METHODOLOGICAL 
CONSIDERATIONS 
In this chapter methodological considerations of some state-of-
the-art methods used in the Papers I-III are given. For detailed 
experimental procedures of all used techniques, please refer to the 
Material and Methods parts of the respective paper. 
2.1 Mouse models – genetic ablation of intermediate 
filament proteins in mice (Paper I-III) 
To study the role of intermediate filament proteins GFAP, 
vimentin and nestin we used mice deficient for GFAP and vimentin 
(GFAP-/-Vim-/-, Paper I) or nestin (Nes-/-, Paper II). 
We used Nes-/- mice and their respective wild-type controls on 
a mixed genetic background (C57BL/6(B6)-129/Sv). The Nes-/- mice 
are viable and reproduce normally [159]. CNS organization in Nes-/- 
mice shows no major defects, but nestin seems to be essential for the 
distribution of acetylcholine receptors at neuromuscular junctions 
[159]. In contrast to the Nes-/- mice used here, Park et al. [160] reported 
that Nes-/- mice generated in their lab showed embryonic lethality and 
in vitro experiments decreased self-renewal capability of Nes-/- NSCs 
derived from embryonic CNS. However, for the generation of our 
mice, several ES clones were used to generate several mouse lines 
deficient for nestin in parallel, while the Nes-/- mice of Park et al. were 
generated from only a single ES clone. All Nes-/- mice lines generated 
in the lab of Prof. Andras Nagy showed the same phenotype and in 
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immunocytochemical and Western blot analyses of Nes-/- mice nestin 
protein was not detectable. 
GFAP-/-Vim-/- mice and their respective wild-type controls are 
on a mixed genetic background (C57Bl/6-129Sv-129Ola) and they are 
viable and reproduce normally [161-164]. Since nestin cannot 
polymerize with itself into intermediate filaments [56], GFAP-/-Vim-/- 
astrocytes are completely devoid of intermediate filaments; the mice 
show attenuated reactive gliosis and glial scar formation [162]. 
However, synaptic and axonal regeneration [30, 165, 166], 
transplantation of neural grafts and neural stem cells are improved 
[167, 168], and in addition, basal and posttraumatic hippocampal 
neurogenesis is increased [49, 169].  
2.2 In vitro - the cell culture systems  
2.2.1 Bioactive3D – a novel in vivo-like 3-dimensional cell culture 
system – compared to conventional 2-dimensional culture systems 
(Paper III) 
To study the function of astrocytes in vitro, primary astrocytes 
are commonly cultured in 2-dimensional (2D) systems on coated or 
un-coated plastic or glass surfaces in the presence of a high percentage 
(10%) of fetal calf serum (FCS). Those 2D-cell culture systems 
constitute a highly artificial and stressful environment, where 
astrocytes are forced to grow without the 3-dimensional (3D) support. 
Astrocytes in 2D-cell cultures resemble reactive astrocytes, since they 
exhibit increased proliferation, up-regulate the expression of GFAP 
and vimentin, re-express nestin and alter gene expression, cell 
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morphology and function. Over the last years, several attempts have 
been made, to design 3D cell culture systems that provide a less 
stressful culture environment by giving structural 3D-support to 
preserve the cell morphology and function that allow in vitro studies in 
a more in vivo-like environment. Up to date, available 3D-cell culture 
systems are based on alginate scaffolds, collagen gels or hydrogels 
[170-172] or are comprised of polymer, ceramics or macroporus 
scaffolds [173, 174], all of which exhibit several disadvantages. Gels 
prevent extensions of cell processes and prolong diffusion of released 
molecules. Further, cell type specific coating of gels is impossible. 
Rigid polymer, ceramics or macroporus scaffolds can lead to unwanted 
clustering and compartmentalization of cells [173, 174]. To circumvent 
these problems and to create a more in vivo-like environment for 
cultured astrocytes, we utilized bioactively-coated 3D-nanofiber 
scaffolds and established a novel 3D-cell culture system 
(Bioactive3D). Nanofibers were prepared by electrospinning using a 
biocompatible polyether-based polyurethane resin in a 60:40 mixture 
of tetrahydrofuran and N,N-dimethylformamide and the nanofibres 
were subsequently coated with poly-L-ornithine and laminin [175].  
Astrocytes grown in Bioactive3D maintain their complex in 
vivo-like morphology (Fig. 6) and motility of cell filopodia is 
supported. Further, we demonstrated that astrocytes grown in 
Bioactive3D are less exposed to cell culture stress compared to 
astrocytes, grown in conventional 2D-cell culture systems, which 
results in decreased expression of GFAP, vimentin, synemin and 
nestin, reduced proliferation and altered expression of genes involved 
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in regulation of proliferation, cell shape determination and cell motility 
[176]. The Bioactive3D cell culture system allows us to study the 
function of primary astrocytes in vitro since these astrocytes are less 
reactive and keep some in vivo-like properties. 
 
 
 Fig. 6 Morphological differences of 
astrocytes cultured in 2D and 
Bioactive3D. Primary astrocytes 
cultured in Bioactive3D show in vivo-
like morphology (right) compared to flat 
and polygonal shaped astrocytes 
cultured in conventional 2D cell culture 
systems (left). Puschmann et al. 2013. 
 
2.2.2 Neurosphere cultures (Paper II) 
The possibilities to investigate intrinsic molecular properties of 
NSCs in vivo are limited and often impossible. One in vitro system, to 
study the cell intrinsic mechanisms of NSCs is the neurosphere assay 
that has been commonly used to address cell proliferation, self-renewal 
and differentiation of NSCs into neurons, astrocytes and 
oligodendrocytes. The neurosphere assay is based on the theory that 
NSCs, cultured in presence of growth factors but without FCS, divide 
symmetrically and build non-adherent, free-floating clusters of 
multipotent daughter stem cells that are able to differentiate after 
growth factor removal. However, it was reported, that neurospheres are 
heterogeneous cell clusters consisting of symmetrically, slowly 
dividing NSCs, but also of more restricted progenitor cells, which 
divide rapidly. Further it was shown, that the free-floating 
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neurospheres are able to merge and even exchange cells with each 
other, questioning the pure “stemness” and ”clonality” of the cells 
within one neurosphere (for review see [177]). Therefore caution is 
advised, when using neurosphere forming capacity (the number of 
neurospheres formed) or the size of neurospheres as an indicator of 
how many NSCs may exist in vivo and what their proliferative 
capability is. Further it needs to be considered, that cells that are not 
NSCs can acquire stem cell properties when cultured in the presence of 
growth factors and they can also form neurospheres.  
 
2.2.3 The establishment of NSC lines from adult mice (Paper II) 
To investigate the functional role of nestin in cell intrinsic 
properties of adult NSCs, we established neural stem cell lines of adult 
Nes-/- and the corresponding wild-type control mice in our lab. The 
NSC lines were established from brains (without olfactory bulb and 
cerebellum) of 4-5 week old mice of both genders. At 4-5 weeks of age 
mice have reached maturity and are considered adult animals. The 
established cell lines were cultured for at least 25 passages to verify 
their stemness, proliferative capability and their capability to generate 
neurons and astrocytes. Adult NSC lines generated from male or 
female animals did not show differences in their stemness, 
proliferative capability or their capability to generate neurons and 
astrocytes. However, the NSC lines used in paper II were derived from 
male animals and all experiments were performed with NSCs of 
passage 5-7. Proliferation was assessed using a hemocytometer and 
differentiation capability was assessed by immunocytochemical 
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detection of cell type specific markers (βIII-tubulin for neurons and 
S100β for astrocytes). Directional migration towards a SDF-1α 
gradient was assessed as previously described [178] using a 
chemotaxis chamber. 
 
2.2.4 Astrocyte co-cultures with rat NSCs derived from adult 
hippocampus (Paper II) 
To investigate the effect of the astrocyte (wild-type and Nes-/-) 
environment on neuronal differentiation of NSCs, primary mouse 
astrocytes were co-cultured with NSCs. The NSCs were derived from 
adult rat hippocampus and retrovirally transfected to express green 
fluorescent protein (GFP). The NSC cell line (clone HCN-A94/GFPH) 
was kindly provided by F.H. Gage (Salk Institute, La Jolla, CA, USA). 
For all co-culture experiments NSCs of passage 19-20 were used, a 
passage in which GFP expression was detected in only a fraction of all 
NSCs. Therefore, proliferating NSCs were labeled with 5-bromo-2-
deoxyuridine (BrdU) for 48h before plating them on top of primary 
astrocytes. Total cell number was evaluated by counting BrdU positive 
cells, while differentiation properties of NSCs were addressed with 
antibodies against GFAP for astrocytes and βIII-tubulin for neurons. It 
needs to be considered that BrdU has a low genotoxicity and changes 
the methylation pattern of the DNA, which may influence the 
differentiation of NSCs (see also paragraph 2.4). The reason, why rat 
NSCs were used instead of mouse NSCs was primarily because the rat 
NSC line was available in our laboratory and has been used in similar 
experiments with GFAP-/-Vim-/- astrocytes before [168]. 
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2.3 Quantitative real-time PCR (RT-qPCR) of individual 
astrocytes (Paper I) 
Heterogeneity of cells on the levels of mRNA, proteins, 
metabolites or lipids within an apparently homogenous cell type is 
acknowledged since many years. However, technical limitations in the 
past prevented transcriptomical, proteomical, metabolomical or 
lipidomical analyses on the level of individual cells. Up to date, single 
cell analyses were mainly based on immunocytochemical, 
immunohistochemical or flow-cytometric methods restricting the 
number of analyzed genes, proteins or metabolites per cell to only a 
few, which makes it almost impossible to decipher the complexity of 
biological processes, such as signaling pathways, in detail. The rapid 
pace of technological development within the last few years makes it 
now possible to address heterogeneity on single cell level revealing 
unique molecular signatures of individual cells (for review see [179]). 
One approach to target heterogeneity among astrocytes is by 
means of mRNA expression levels using quantitative real-time PCR 
(RT-qPCR) in individual astrocytes. The amount of mRNA molecules 
per gene can vary between only a few copies to up to 50.000 molecules 
per individual astrocyte [180]. This difference is masked in RT-qPCR 
analyses of astrocyte populations, but on the level of individual cells 
gives us an accurate representation of variations as well as correlations 
of gene expression within astrocytes to classify subpopulations and/or 
reveal a detailed picture of signaling mechanisms (Fig. 7).  
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Fig. 7 Heterogeneity of mRNA expression and correlation. RT-qPCR analyses of cell 
populations cannot distinguish between A) and B) or C) and D).  
The mRNA content of one individual mammalian cell is 
usually about 1pg of mRNA, which corresponds to approximately 
300.000 mRNA molecules of about 10.000 existing genes [181, 182]. 
RT-qPCR is highly sensitive and detection of only one mRNA 
molecule, corresponding to only femtograms of mRNA, within one 
cell is possible; further advantages are the wide dynamic range and 
high reproducibility of RT-qPCR [183-185]. Technical variability of 
RT-qPCR analyses due to minimal mRNA material was shown to be 
minute in comparison to the biological variability occurring in gene 
expression of individual cells [186].  
Genes of interest, also splice variants of the same gene, can be 
specifically selected and pre-amplification of mRNA makes it possible 
to analyze up to 100 genes per individual cell [187].  
The classification of possible subpopulations of heterogeneous 
cell types by RT-qPCR is based on mRNA levels. Differences in 
mRNA levels do not necessarily lead to alterations in protein 
expression, morphological or functional differences. Posttranslational 
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mRNA modifications affect translation of mRNA into proteins; 
further, transcription is a highly dynamic process and half-life for 
specific mRNA molecules is gene-dependent. In addition, protein 
modifications such as phosphorylation, dephosphorylation as well as 
glycosylation alter the functional properties of proteins.  
 
2.4 BrdU labeling of proliferating cells and cell fate 
determination (Paper II and III) 
To detect the small population of dividing neural stem cells in 
the adult mammalian brain, BrdU in vivo labeling is commonly used. 
BrdU is incorporated into the replicating DNA of dividing cells as well 
as during DNA repair mechanisms as a thymidine analogue, followed 
by immunohistochemical detection. Incorporation of BrdU into 
dividing cells in vivo allows to address the existing number of NSPCs 
in the CNS and to follow the survival and cell fate determination of 
neural stem cells in CNS over time. The amount of incorporated BrdU 
during DNA repair mechanisms is much lower compared to the 
amount incorporated during DNA replication and is therefore 
negligible. BrdU is known to be genotoxic, which may result in 
malformations when administered during embryogenic development 
[188], however the toxicity is considered to be very low and it was 
shown that hippocampal neurogenesis was not affected in adult rats by 
multiple BrdU injections [189, 190]. The ideal dosage of BrdU, 
administered intraperitonally and shown to be non-toxic, for the 
detection of all dividing cells lays between 100-300mg/kg [189]. 
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We administered BrdU intraperitonally to label and follow the 
cell fate of newly born cells in the adult brain of Nes-/- mice in vivo at a 
dose of 200mg/kg. Total number of BrdU positive cells was calculated 
to address the existing pool of proliferating NSPCs within different 
regions of the adult brain. For cell fate determination, double labeling 
of BrdU with S100β was used to determine the number of newly 
formed astrocytes, double labeling of BrdU with NeuN was used to 
address newly generated neurons, double labeling of BrdU with GFAP 
was used to address the number of NSCs (corresponding to type 1 cells 
also known as radial glia-like cells) and double labeling of BrdU with 
doublecortin (Dcx) was used to address the number of neuronal 
precursor and immature neurons (corresponding to type 2-3 cells also 
known as non-radial precursors or IPCs) [191]. 
BrdU labeling can also be used for detection of proliferating 
cells in vitro (see paragraph 2.2.3). An alternative possibility to label 
proliferating cells in vitro is by using 5-ethynyl-2`-deoxyuridine (EdU) 
instead of BrdU (Paper III). The mechanism of incorporation into the 
DNA of replicating cells as a thymidine analogue remains the same. 
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3 AIMS OF THE THESIS 
 
I) To study (i) the heterogeneity of astrocytes on a 
single cell level with a particular focus on the Notch 
signaling pathway, (ii) the effect of the intermediate 
filament (nanofilament) proteins GFAP and 
vimentin on the Notch signaling competence of 
individual astrocytes, and (iii) to identify possible 
astrocyte subpopulations based on mRNA 
expression of individual astrocytes (Paper I). 
II) To investigate the role of the intermediate filament 
protein nestin (i) in neural stem/progenitor cell 
proliferation, differentiation and directional 
migration in vitro, and (ii) in the neurogenesis in the 
two adult neurogenic niches, the dentate gyrus of the 
hippocampus and the subventricular zone of the 
lateral ventricles (Paper II). 
III) To address the effect of heparin binding EGF-like 
growth factor (HB-EGF) on (i) astrocyte 
morphology, (ii) proliferation, (iii) differentiation, 
(iv) expression of intermediate filament proteins and 
(iv) mRNA expression of selected genes in our 
newly developed 3 dimensional cell culture system 
(Bioactive3D) and in conventional 2 dimensional 
cell culture systems (Paper III). 
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4 RESULTS AND DISCUSSION 
Paper I 
Heterogeneity of Notch signaling in astrocytes and the effects of 
GFAP and vimentin deficiency  
Astrocytes are a multifunctional and highly heterogeneous cell 
type and fulfill many roles in healthy and injured CNS. Recently, we 
showed, that astrocytes actively participate in the regulation of 
neurogenesis by inhibiting neuronal differentiation of NSPCs through 
Jag1-mediated Notch signaling and that this regulation is dependent on 
the cytoplasmic intermediate filament proteins GFAP and vimentin 
[49]. Here we show the heterogeneity of astrocytes with regard to their 
Notch signal sending competence on a single cell level.  
We found that most astrocytes are competent to receive Notch 
signals (defined as astrocytes that express the Notch1 receptor), while 
only a minority of astrocytes is competent to send Notch signals 
(defined as astrocytes that express one of the Notch ligands, Jag1 or 
Dlk2) and even fewer astrocytes can send as well as receive Notch 
signals (defined as astrocytes that express one of the Notch ligands, 
Jag1 and Dlk2, and the Notch1 receptor). Only Notch signal sending 
competence seems to depend on GFAP and vimentin since fewer 
GFAP-/-Vim-/- astrocytes have Notch signal sending competence, 
whereas the size of the Notch signal receiving competent population of 
GFAP-/-Vim-/- astrocytes is comparable to wild-type astrocytes. 
Gene expression of Notch signal pathway genes Notch1, Dlk2 
and Sox2 is differentially regulated in GFAP-/-Vim-/- astrocytes, with up 
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to a 1.5-fold increase in Dlk2 mRNA levels in GFAP-/-Vim-/- astrocytes 
compared to wild-type, while fewer GFAP-/-Vim-/- astrocytes express 
Dlk2 in general. Further, Sox2 and Dlk2 mRNA expression is only 
correlated in wild-type astrocytes but is absent in GFAP-/-Vim-/- 
astrocytes. Since Dlk2 was reported as an inhibitory Notch ligand that 
modulates the activity of other Notch ligands, GFAP-/-Vim-/- astrocytes 
may send more inhibitory Notch signals compared to wild-type 
astrocytes, which affect gene expression and correlation of the 
remaining Notch signal pathway related genes. The Notch signal 
pathway lacks an enzymatic amplification step but is sensitive to the 
gene dosage, therefore already small changes in the amount of mRNA 
molecules of Notch pathway genes may affect the signaling outcome 
in GFAP-/-Vim-/- astrocytes. 
To our knowledge, this is the first study to address 
heterogeneity of signaling competence in individual astrocytes and it 
heralds the importance of single cell analyses for a better 
understanding of cell-cell interactions. 
 
Nestin and HB-EGF are possible classifier for astrocyte 
subpopulations  
Astrocytes have complex functions in healthy and diseased 
CNS and are also able to de-differentiate and regain stem cell 
characteristics after injury or neurotrauma. This heterogeneity of 
astrocytes makes classifications of astrocyte subpopulations based on 
expression of specific markers highly desirable since up to date no 
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specific markers are known to classify possible astrocyte 
subpopulations in vivo or in vitro. 
Nestin (Nes) and HB-EGF mRNA expression can be used to 
classify both wild-type and GFAP-/-Vim-/- astrocyte subpopulations. 
Nes and HB-EGF mRNAs are both expressed in immature astrocytes 
[56, 158] and are re-expressed in CNS after injury [74, 150, 151, 192]. 
In addition, nestin serves as a marker for NSCs [193], reactive 
astrocytes and astrocytes in a de-differentiated state [194, 195]. Here 
we showed that in vitro Nes serves as a classifier in wild-type and 
GFAP-/-Vim-/- astrocytes in the same manner, while the function of HB-
EGF as a classifier seems to depend on the expression of GFAP and 
vimentin. NesPOS and HB-EGFPOS subpopulations of both wild-type 
and GFAP-/-Vim-/- astrocytes may resemble either a more immature 
astrocyte subpopulation or they represent reactive astrocytes. Since 
nestin usually polymerizes with vimentin, both theories go in line with 
the finding, that vimentin mRNA levels were decreased in NesNEG and 
HB-EGFNEG subpopulations in wild-type astrocytes. 
We propose Nes and HB-EGF mRNA as a possible classifier 
for astrocyte subpopulations in vitro.  
 
Paper II 
The absence of nestin does not affect proliferation of adult NSPCs in 
vivo and in vitro 
The intermediate filament protein nestin is commonly used as a 
marker of neural stem/progenitor cells (NSPCs) and is expressed in 
NSPCs in the adult subgranular zone (SGZ) of the dentate gyrus in the 
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hippocampus and in the subventricular zone (SVZ) of the lateral 
ventricles [3, 16]. Nestin is also re-expressed when astrocytes become 
reactive [56, 74]. However, the role of nestin in embryonic and adult 
neurogenesis remains elusive. Here we investigated the role of nestin 
in neurogenesis in Nes-/- mice. 
We found that nestin does not affect proliferation of adult 
NSPCs or neuroblasts from the two adult germinal zones in Nes-/- and 
wild-type mice in vivo. Proliferation, differentiation and directional 
migration of NSPCs derived from adult Nes-/- and wild-type brains was 
comparable. Previous reports suggested, that nestin is essential for 
proliferation of neural progenitor cells [196] and required for normal 
zebra fish brain and eye development through control of neural 
progenitor cell apoptosis [197]. However, those findings were based on 
knock down techniques in embryonic stem cells and the same 
mechanisms might not apply to adult NSPCs. Recently, nestin was 
shown to not be essential for the development of the CNS [159], 
suggesting, that the role of nestin during CNS development can be 
compensated by other proteins.  
 
Increased adult neurogenesis in the hippocampal dentate gyrus of 
mice deficient for nestin  
The hippocampus of Nes-/- mice had 48%-58% more neurons 
compared to wild-type mice 6 weeks after BrdU administration, 
whereas we did not see a difference 2 weeks after BrdU 
administration. These data imply that the process of survival of newly 
born neurons is altered at a later stage of neuronal maturation and 
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integration in Nes-/- mice. Survival of newly born neurons is dependent 
on the activity and functional integration into the cellular environment. 
Increasing evidence supports the theory of astrocytes as key 
modulators of the neurogenic niches, since astrocytes can share 
characteristic properties with neural stem cells [198-200] and can also 
create a neurogenesis-supportive milieu [201]. The molecular 
mechanisms by which astrocytes control neurogenesis, neural 
plasticity and regeneration are affected by the expression of the 
intermediate filament proteins GFAP and vimentin. In concordance 
with our recent finding, that GFAP-/-Vim-/- deficient astrocytes provide 
a more pro-neurogenic milieu compared to wild-type astrocytes [49], 
we show here that adult rat NSCs gave rise to a higher percentage of 
neurons in co-cultures with Nes-/- compared to wild-type astrocytes. In 
addition, under differentiation conditions, neuronal differentiation of 
P4.5 Nes-/- neurosphere-derived cells was increased compared to wild-
type. These data suggest that Nes-/- astrocytes provide a more pro-
neurogenic environment than wild-type astrocytes. Moreover, the 
results from co-culture experiments suggest that this pro-neurogenic 
effect depends on cell-cell contact. 
Astrocytes in the unchallenged hippocampus do express no or 
very low levels of nestin, while neural stem cells in the hippocampus 
are nestin positive. Therefore, the pro-survival environment in Nes-/- 
mice may rather be provided by other cells, such as neural stem cells 
than astrocytes. The survival and integration of adult-born neurons 
may depend on several factors, such as excitation through NMDA 
receptors [202], activation of TrkB receptors by brain-derived 
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neurotrophic factor [203, 204], Notch signaling [132] or intracellular 
activation of Cdk5 [205, 206]. The exact role of nestin in this process 
remains to be elucidated. 
As astrocytes control the microenvironment of neurons and in 
particular synaptic function, not least by an active uptake of 
neurotransmitters, it is not surprising that they regulate also the 
survival of newly born neurons and their integration into the existing 
networks. Our results provide support for such a scenario, although the 
mechanisms by which nestin and perhaps other intermediate filament 
proteins and their networks control this process remain elusive. Further 
analysis of the role of nestin in this process may provide important 
clues on how intermediate filament proteins and the intermediate 
filament network affect the ability of astrocytes to control neurogenesis 
and perhaps also other aspects of neuronal function. 
 
Paper III 
HB-EGF affects astrocyte proliferation and alters astrocyte morphology 
towards a radial glia-like phenotype  
Astrocytes are usually cultured in 2D-cell culture systems in 
the presence of a high percentage of FCS. FCS is an essential, but 
highly undefined, component to maintain and expand astrocyte 
cultures and it is known to alter astrocyte properties, such as gene 
expression, proliferation and morphology. Recently, HB-EGF was 
suggested as a replacement for serum in astrocyte cultures [158]. 
Additionally, it was shown, that HB-EGF induces de-differentiation of 
Müller glia into multipotent progenitors in zebra fish retinas [157].  
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Here we utilized the Bioactive3D system [176] to address the 
effect of HB-EGF on astrocyte morphology, proliferation, 
differentiation, expression of intermediate filament proteins and 
mRNA expression of selected genes. 
In the presence of HB-EGF we observed a stronger increase in 
proliferation in Bioactive3D compared to 2D cultured astrocytes, 
which may be due to the lower baseline reactivity of astrocytes in the 
Bioactive3D culture system [176]. Alterations of astrocyte morphology 
induced by HB-EGF lead to a more radial glia-like phenotype. A 
similar de-differentiating phenotype was observed after conditioned 
media to the cell cultures from astrocytes in an in vitro injury model 
[194] and it was also reported that HB-EGF is released after injury in 
vivo [207].   
 
HB-EGF affects astrocyte intermediate filament expression and leads to 
partial astrocyte de-differentiation 
In line with the observed morphological changes towards a 
radial glia-like phenotype, we found that HB-EGF leads to an increase 
in the expression of the intermediate filament protein nestin, a marker 
for reactive astrocytes [192], neural progenitor cells [193] and also de-
differentiating astrocytes [194, 195] in both cell culture systems. Notch 
signaling enhances nestin expression in human gliomas [208] and here 
we show that expression of Notch signal pathway related genes was 
differentially affected in both culture systems. mRNA expression of 
the Notch signal pathway ligand Dll1 was up-regulated in both culture 
systems, while its suppressor Hes1 was down-regulated only in 
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Bioactive3D. This may be an indication of a HB-EGF-induced 
amplified Notch signaling cascade in Bioactive3D compared to 2D 
cultures.  
Taken together, the changes in astrocyte morphology towards a 
radial glia-like phenotype, increased nestin protein expression and the 
differential expression of Notch signal pathway related genes, indicate 
that the addition of HB-EGF leads to a partial de-differentiation of 
astrocytes in vitro. Thus, HB-EGF should be used as a component of 
astrocyte culture media only with caution. 	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